Fundus Autofluorescence in Age-related Macular Degeneration.
: Fundus autofluorescence (FAF) provides detailed insight into the health of the retinal pigment epithelium (RPE). This is highly valuable in age-related macular degeneration (AMD) as RPE damage is a hallmark of the disease. The purpose of this paper is to critically appraise current clinical descriptions regarding the appearance of AMD using FAF and to integrate these findings into a chair-side reference. A wide variety of FAF patterns have been described in AMD, which is consistent with the clinical heterogeneity of the disease. In particular, FAF imaging in early to intermediate AMD has the capacity to reveal RPE alterations in areas that appear normal on funduscopy, which aids in the stratification of cases and may have visually significant prognostic implications. It can assist in differential diagnoses and also represents a reliable, sensitive method for distinguishing reticular pseudodrusen. FAF is especially valuable in the detection, evaluation, and monitoring of geographic atrophy and has been used as an endpoint in clinical trials. In neovascular AMD, FAF reveals distinct patterns of classic choroidal neovascularization noninvasively and may be especially useful for determining which eyes are likely to benefit from therapeutic intervention. FAF represents a rapid, effective, noninvasive imaging method that has been underutilized, and incorporation into the routine assessment of AMD cases should be considered. However, the practicing clinician should also be aware of the limitations of the modality, such as in the detection of foveal involvement and in the distinction of phenotypes (hypo-autofluorescent drusen from small areas of geographic atrophy).
*BOptom(Hons), GradCertOcTher †BSc(Hons), PhD ‡MBBS, MBiomedE, FRANZCO §MScOptom, PhD, FAAO Centre for Eye Health, Sydney, New South Wales(AL, LN-S, NA, MK); School of Optometry and Vision Science, University of New South Wales Australia, Sydney, New South Wales(AL, LN-S, MK); and Department of Ophthalmology, Prince of Wales Hospital, Randwick, New South Wales, Australia(NA).
Angelica
A
Ly
Lisa
L
Nivison-Smith
Nagi
N
Assaad
Michael
M
Kalloniatis
D020256:Choroidal Neovascularization / Q000175:diagnosis*; D005451:Fluorescein Angiography / Q000379:methods*; D005654:Fundus Oculi; D006801:Humans; D009887:Ophthalmoscopy; D010641:Phenotype; D055213:Retinal Pigment Epithelium / Q000473:pathology*; D057135:Wet Macular Degeneration / Q000175:diagnosis*
Graefes Arch Clin Exp Ophthalmol. 2012 Apr;250(4):485-90
22033626
Retina. 2014 Jul;34(7):1281-8
24695062
Ophthalmology. 2009 Apr;116(4):771-82, 782.e1
19243827
Am J Ophthalmol. 2013 Feb;155(2):260-269.e2
23111182
Ophthalmology. 2013 Jun;120(6):1271-7
23433790
Am J Ophthalmol. 2009 Sep;148(3):439-44
19541290
Retina. 2010 Jan;30(1):6-15
20066766
Ophthalmic Res. 2014;52(2):53-9
24993093
Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):27-34
22580948
Prog Retin Eye Res. 2014 Mar;39:23-57
24291520
Ophthalmology. 2011 Sep;118(9):1844-51
21496928
Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2648-54
16723482
Graefes Arch Clin Exp Ophthalmol. 2013 Dec;251(12):1-9
23677486
Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5495-504
17122141
Ophthalmology. 2008 Feb;115(2):342-6
17599415
Acta Ophthalmol. 2012 Jun;90(4):e281-7
22269083
Ophthalmologica. 2011;226(3):110-8
21822000
Lancet Glob Health. 2014 Feb;2(2):e106-16
25104651
Genet Mol Res. 2013 Dec 02;12(4):6140-8
24338407
Invest Ophthalmol Vis Sci. 2012 Jul 26;53(8):4932-9
22661483
Br J Ophthalmol. 2012 Sep;96(9):1211-6
22826551
Br J Ophthalmol. 2007 Apr;91(4):491-6
16956913
Br J Ophthalmol. 1995 May;79(5):407-12
7612549
Retina. 2012 Oct;32(9):1884-91
22547167
Retina. 2012 Oct;32(9):1829-37
22850219
Ophthalmic Res. 2012;47(2):81-6
21757965
Graefes Arch Clin Exp Ophthalmol. 2007 Oct;245(10):1453-60
17429674
Graefes Arch Clin Exp Ophthalmol. 2005 Apr;243(4):300-5
15864618
Retina. 2013 Jun;33(6):1241-8
23508076
Ophthalmology. 2013 Feb;120(2):334-41
23137630
Invest Ophthalmol Vis Sci. 2011 Dec 16;52(13):9497-502
22110076
Retina. 2013 Mar;33(3):490-7
23403515
Semin Ophthalmol. 2011 May;26(3):209-15
21609234
Retina. 2015 Apr;35(4):742-9
25412037
Ophthalmology. 2012 Jun;119(6):1199-210
22449572
Retina. 2014 Jan;34(1):69-76
23743636
Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3915-21
19339734
Am J Ophthalmol. 2013 Sep;156(3):532-42.e1
23830564
Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):8908-18
22003107
Ophthalmology. 2014 Sep;121(9):1748-55
24856310
Invest Ophthalmol Vis Sci. 2012 Apr 24;53(4):2193-8
22410571
Am J Ophthalmol. 2009 Nov;148(5):733-743.e2
19878758
Zhonghua Yan Ke Za Zhi. 2010 Aug;46(8):708-13
21054995
Ophthalmology. 2003 Feb;110(2):392-9
12578786
Ophthalmologica. 2011;225(3):144-9
21071996
Invest Ophthalmol Vis Sci. 2011 Jan 05;52(1):1-6
20688734
Retina. 2011 Mar;31(3):518-26
21150696
Retina. 2013 Oct;33(9):1850-62
23632954
Am J Ophthalmol. 2007 Mar;143(3):463-72
17239336
Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251(3):705-14
22814526
Osaka City Med J. 2009 Jun;55(1):19-27
19725431
Optom Vis Sci. 2014 Aug;91(8):832-48
24879089
Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3309-14
16123434
Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3095-9
18378583
Ophthalmic Surg Lasers Imaging. 2006 Sep-Oct;37(5):406-14
17017200
Br J Ophthalmol. 2011 Jul;95(7):979-85
21109695
Br J Ophthalmol. 2005 Jul;89(7):874-8
15965170
Acta Ophthalmol. 2012 Sep;90(6):e428-33
22578271
Optom Vis Sci. 2014 Aug;91(8):950-5
24987815
Invest Ophthalmol Vis Sci. 2011 Aug 24;52(9):5009-15
21498612
Ophthalmology. 2013 Apr;120(4):844-51
23332590
Retina. 2011 Jan;31(1):81-6
20890245